MRI Contrast Enhancement by MnTPPS of Experimental Brain Tumours in Rats
In the experimental F98 rat glioma model the nuclear magnetic resonance contrast agent MnTPPS was used to increase the contrast between tumour and peritumourous brain tissue. By evaluating pre-and postcontrast CPMG echo trains after different dose and circulation times of MnTPPS, the transverse relaxation time T2, the magnetization extrapolated to the time zero M (0), and the contrast ratio Rc of the magnetizations in neoplastic and normal tissues were determined. According to these data a maximum contrast is obtained a few hours after injection of 0.25 mmol MnTPPS/kg bw, using spin echo pulse sequences with short repetition times TR (1,100 ms), and short spin echo time TE (25 ms).
KeywordsContrast Ratio Transverse Relaxation Time Spin Echo Pulse Sequence Experimental Glioma Experimental Brain Tumour
Unable to display preview. Download preview PDF.
- 1.Bockhorst K, Höhn-Berlage M, Kocher M, Hossmann KA (1990) Proton relaxation enhancement in experimental brain tumours. In vivo NMR study of manganese (III) TPPS in rat brain gliomas. Magn Reson Imaging (in press)Google Scholar
- 4.Junck L, Olson JMM, Ciliax BJ, Koeppe RA, Watkins GL, Jewett DM, McKeever PE, Wieland DM, Kilbourn MR, Starosta-Rubinstein S, Mancini WR, Kuhl DE, Greenberg HS, Young AB (1989) PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann Neurol 26: 752–758PubMedCrossRefGoogle Scholar
- 5.Patronas NJ, Cohen JS, Knop RH, Dwyer AJ, Colcher D, Lundy J, Mornex F, Hambright P, Sohn M, Myers CE (1986) Metalloporphyrin contrast agents for magnetic resonance imaging of human tumours in mice. Cancer Treat Rev 70: 391–395Google Scholar